Radiologically isolated syndrome
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
<b>Methods:</b> Here we compared neurofilament light chain (NFL) and progranulin (PGRN) levels in the CSF in RIS patients with levels in patients with different subtypes of MS and healthy controls (HC) using Kruskal-Wallis one-way analysis of variance.
|
30619038 |
2018 |
Neurodegenerative Disorders
|
0.100 |
Biomarker
|
group |
BEFREE |
<b>Objectives:</b> Elevated neurofilament light chain (NFL) levels within the cerebrospinal fluid (CSF) are a biomarker representing axonal neurodegeneration in rapid progressive neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).
|
30631300 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Objectives:</b> Elevated neurofilament light chain (NFL) levels within the cerebrospinal fluid (CSF) are a biomarker representing axonal neurodegeneration in rapid progressive neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).
|
30631300 |
2018 |
Huntington Disease
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
11 premanifest HD and 12 manifest HD subjects were enrolled.NFL and tau levels were correlated.
|
28241046 |
2017 |
Alzheimer's Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
545 eligible non-Hispanic white participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) with longitudinal plasma NFL data were included.
|
31295725 |
2019 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous disorder that has been associated with alterations of several proteins: peripheral myelin protein 22, myelin protein zero, connexin 32, early growth response factor 2, periaxin, myotubularin related protein 2, N-myc downstream regulated gene 1 product, neurofilament light chain, and kinesin 1B.
|
11835375 |
2002 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth neuropathy (CMT) 2E/1F is caused by mutations in the neurofilament light-chain polypeptide (NEFL) gene.
|
27649278 |
2017 |
Impaired cognition
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.
|
29797629 |
2018 |
hearing impairment
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Hearing impairment is often linked to CMT due to pathogenic variants of NEFL, especially p.(Glu90Lys) and p.(Asn98Ser), and in our case p.(Glu90Gly).
|
30734407 |
2019 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E (disorder)
|
0.950 |
Biomarker
|
disease |
BEFREE |
Charcot-Marie-Tooth disease Type 2E/1F (CMT2E/1F) is a peripheral neuropathy caused by mutations in neurofilament protein L (NFL), which is one of five neurofilament subunit proteins that co-assemble to form neurofilaments in vivo.
|
31574566 |
2019 |
Postoperative delirium
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Postoperative delirium is associated with increased plasma neurofilament light.
|
31802104 |
2020 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: nonsense mutation probably causes a recessive phenotype.
|
19158810 |
2009 |
Leukoencephalopathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Neurofilament light (NFL) proteins in cerebrospinal fluid (CSF) are a marker of neuronal damage, especially subcortical axonal injury and white matter disease.
|
21983493 |
2012 |
Secondary malignant neoplasm of lymph node
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
NEFL mRNA was found to be expressed in 92.3% of breast malignancies and down-regulated in lymph node metastases compared to the paired primary tumors.
|
22319610 |
2012 |
Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
NEFL mRNA was found to be expressed in 92.3% of breast malignancies and down-regulated in lymph node metastases compared to the paired primary tumors.
|
22319610 |
2012 |
Malignant neoplasm of breast
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
NEFL mRNA level was lower in primary breast cancers with positive lymph nodes than in cancers with negative lymph nodes.
|
22319610 |
2012 |
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
NEFL, one of the in silico hypermethylated genes in cancer, showed hypermethylation and lower expression in the cancer cell line MDA-MB-231, as well as in cancer tissues (methylation, p<0.05; expression, p<0.01).
|
24026393 |
2013 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
NEFL, one of the in silico hypermethylated genes in cancer, showed hypermethylation and lower expression in the cancer cell line MDA-MB-231, as well as in cancer tissues (methylation, p<0.05; expression, p<0.01).
|
24026393 |
2013 |
Motor Neuron Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
NEFL mutations are known to cause Charcot-Marie-Tooth disease in humans and motor neuron disease in mice.
|
25264603 |
2014 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NEFL mutations have been previously linked to Charcot-Marie-Tooth disease in humans.
|
25264603 |
2014 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.
|
25552649 |
2015 |
Charcot-Marie-Tooth Disease
|
0.300 |
Biomarker
|
disease |
MGD |
Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.
|
25552649 |
2015 |
Hereditary Motor and Sensory Neuropathies
|
0.220 |
GeneticVariation
|
group |
BEFREE |
Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs.
|
25583183 |
2014 |
Pyramidal sign
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs.
|
25583183 |
2014 |
Charcot-Marie-Tooth Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.
|
25877835 |
2015 |